Neuroinflammatory signaling

Neuroinflammatory signaling is a complex biological process involving the activation of the innate immune system within the central nervous system (CNS) in response to various stimuli, including infection, trauma, or protein aggregation (DiSabato et al., 2016, Journal of Neurochemistry). This signaling is primarily driven by microglia and astrocytes, which transition to reactive states and release a variety of pro-inflammatory mediators such as cytokines (e.g., TNF-α, IL-1β, IL-6), chemokines, and reactive oxygen species (Glass et al., 2010, Cell). While acute neuroinflammation serves a protective role by clearing debris and pathogens, chronic activation of these pathways is a central driver of neurodegeneration in diseases such as Alzheimer's, Parkinson's, and Multiple Sclerosis (Heneka et al., 2015, Nature). Therapeutic interventions targeting neuroinflammatory signaling often focus on specific molecular nodes, such as the NLRP3 inflammasome, Toll-like receptors (TLRs), or JAK/STAT pathways, to reduce neurotoxicity and slow disease progression (Subhramanyam et al., 2019, Progress in Molecular Biology and Translational Science). Additionally, the modulation of sphingosine-1-phosphate (S1P) receptors and Nrf2 pathways represents established clinical approaches to dampen neuroinflammatory cascades in autoimmune conditions (Kappos et al., 2010, New England Journal of Medicine). However, the dual nature of neuroinflammation—which includes both neurodestructive and neuroregenerative phases—makes precise therapeutic targeting challenging to avoid compromising essential CNS maintenance (Guzman-Martinez et al., 2019, Frontiers in Pharmacology).

Other names

NeuroinflammationCNS inflammatory responseGlial activation signalingNeuro-immune signaling

Modulation of glial activation, inhibition of pro-inflammatory cytokine production, blockade of leukocyte trafficking into the CNS, and activation of antioxidant pathways (e.g., Nrf2).